Nouvelle déclaration d'incident
No de la demande: 2012-0721
Numéro de référence du titulaire d'homologation: 2012 Captan AE (PMRA)
Nom du titulaire (nom légal complet, aucune abbréviation): Captan Task Force c/o Makhteshim Agan of North America, Inc.
Adresse: 3120 Highwoods Boulevard, Suite 100
Ville: Raleigh
État: NC
Pays: USA
Code postal /Zip: 27604
Étude scientifique
ARLA No d'homologation 21107 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: Captan Technical
ARLA No d'homologation 27904 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: CAPTAN TECHNICAL 1
ARLA No d'homologation 18221 ARLA No de la demande d'homologation EPA No d'homologation.
Nom du produit: CAPTAN TECHNICAL FUNGICIDE
Inconnu
Inconnu
Titre The Hershberger Bioassay (OPPTS 890.1400); Captan
Date 05-JAN-12
Non
Nouveau danger pour la santé ou pour l'environnement
Starting on day 4 of the study, animals in the high and mid dose groups started to show signs of abnormal breathing (gasping), abdominal distention, and rapid weight loss. These animals were euthanized in extremis. Upon necropsy the small and large intestines were found to be severely distended with air. Subsequent to symptom onset, all rats died at the high dose in the agonist group (400 mg/kg/day) and in the mid (200 mg/kg/day +TP) and in the high dose (and 400 mg/kg/day + TP, respectively) in the antagonist groups. An assessment of these effects suggest that morbundity is likely due to gavage-related reflux of the test material resulting from a combination of the vehicle, the irritating properties of the test substance and the gavage administration. Therefore, these effects are unlikely to be causally related to the toxicity of the compound.
Non